MX2021003990A - Metodos para detectar agonistas de ubiquitina ligasa. - Google Patents
Metodos para detectar agonistas de ubiquitina ligasa.Info
- Publication number
- MX2021003990A MX2021003990A MX2021003990A MX2021003990A MX2021003990A MX 2021003990 A MX2021003990 A MX 2021003990A MX 2021003990 A MX2021003990 A MX 2021003990A MX 2021003990 A MX2021003990 A MX 2021003990A MX 2021003990 A MX2021003990 A MX 2021003990A
- Authority
- MX
- Mexico
- Prior art keywords
- ubiquitin ligase
- methods
- substrate
- agonist
- neo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/05—Hydrolases acting on acid anhydrides (3.6) acting on GTP; involved in cellular and subcellular movement (3.6.5)
- C12Y306/05002—Small monomeric GTPase (3.6.5.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/02—Aminoacyltransferases (2.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
- C12Y603/02019—Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/9015—Ligases (6)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
- G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Se describen en la presente métodos para identificar un agonista de ubiquitina ligasa, y los métodos incluyen (a) poner en contacto una ubiquitina ligasa con un agonista candidato y un neo-sustrato; y (b) determinar si el agonista candidato es eficaz para dar por resultado la unión de la ubiquitina ligasa al neo-sustrato, en donde la unión del sustrato de ubiquitina al neo-sustrato identifica el agonista candidato como un agonista de ubiquitina ligasa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862746957P | 2018-10-17 | 2018-10-17 | |
PCT/US2019/056738 WO2020081815A1 (en) | 2018-10-17 | 2019-10-17 | Methods for screening ubiquitin ligase agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021003990A true MX2021003990A (es) | 2021-09-10 |
Family
ID=70284783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021003990A MX2021003990A (es) | 2018-10-17 | 2019-10-17 | Metodos para detectar agonistas de ubiquitina ligasa. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20210382054A1 (es) |
EP (1) | EP3867642A4 (es) |
JP (1) | JP2022512742A (es) |
KR (1) | KR20210093890A (es) |
CN (1) | CN112912728A (es) |
AU (1) | AU2019362863A1 (es) |
CA (1) | CA3115824A1 (es) |
MX (1) | MX2021003990A (es) |
WO (1) | WO2020081815A1 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2318538A4 (en) * | 2008-07-25 | 2012-03-14 | Progenra Inc | METHOD OF IDENTIFYING UBIQUITIN LIGASE MODULATORS |
US9464311B2 (en) * | 2013-05-02 | 2016-10-11 | E3X Bio, Inc. | Method for identifying modulators of ubiquitin ligases |
WO2020079103A1 (en) * | 2018-10-16 | 2020-04-23 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Method for identifying a chemical compound or agent inducing ubiquitination of a protein of interest |
-
2019
- 2019-10-17 KR KR1020217014524A patent/KR20210093890A/ko unknown
- 2019-10-17 US US17/283,773 patent/US20210382054A1/en active Pending
- 2019-10-17 WO PCT/US2019/056738 patent/WO2020081815A1/en unknown
- 2019-10-17 MX MX2021003990A patent/MX2021003990A/es unknown
- 2019-10-17 EP EP19874294.2A patent/EP3867642A4/en active Pending
- 2019-10-17 AU AU2019362863A patent/AU2019362863A1/en not_active Abandoned
- 2019-10-17 CN CN201980068080.5A patent/CN112912728A/zh active Pending
- 2019-10-17 JP JP2021521194A patent/JP2022512742A/ja active Pending
- 2019-10-17 CA CA3115824A patent/CA3115824A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20210093890A (ko) | 2021-07-28 |
EP3867642A4 (en) | 2022-08-03 |
JP2022512742A (ja) | 2022-02-07 |
EP3867642A1 (en) | 2021-08-25 |
US20210382054A1 (en) | 2021-12-09 |
WO2020081815A1 (en) | 2020-04-23 |
CN112912728A (zh) | 2021-06-04 |
AU2019362863A1 (en) | 2021-06-03 |
CA3115824A1 (en) | 2020-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020123316A3 (en) | Methods for determining a location of a biological analyte in a biological sample | |
BR112018068703A2 (pt) | inibidores substituídos de menin-mll e métodos de uso | |
MX2017003151A (es) | Region inactiva para una superficie tactil con base en la informacion contextual. | |
BR112018068702A2 (pt) | inibidores bicíclicos em ponte de menin-mll e métodos de uso | |
EA202191023A3 (ru) | Фунгицидные комбинации | |
MA40325A (fr) | Procédés et compositions pour diagnostiquer, pronostiquer et confirmer une pré-éclampsie. | |
MX2017016647A (es) | Anticuerpos y fragmentos anti-vista. | |
BR112012027046A2 (pt) | processo e aparelho para determinar as capacidades de serviço do ponto de acesso | |
ES2570380T3 (es) | Método para determinar la aptitud de inhibidores de EZH2 humano en tratamiento | |
EP3995142A3 (en) | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof | |
MX2017000083A (es) | Compuestos de platino, composiciones y usos de estos. | |
BR112018077253A8 (pt) | Método que envolve um dispositivo médico portátil, sistema, servidor, e, dispositivo cliente. | |
MX2016004865A (es) | Metodo y dispositivo para analizar relacion social. | |
PH12015502849B1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
MX2022013015A (es) | Sistemas y metodos de uso para utilizar en la identificacion de multiples ediciones genomicas y predecir los efectos acumulados de las ediciones genomicas identificadas. | |
BR112019002979A2 (pt) | método de cromatografia para quantificação de um tensoativo não iônico em uma composição compreen-dendo o tensoativo não iônico e um polipeptídeo | |
EP3686290A3 (en) | Method and kits for identifying of cdk9 inhibitors for the treatment of cancer | |
ZA202102546B (en) | Methods for identifying free thiols in proteins | |
EA201891002A1 (ru) | Иммунологический анализ для определения расщепленного высокомолекулярного кининогена | |
PH12016000002B1 (en) | Proactive duplicate identification | |
MX2021002056A (es) | Metodo para depurar especies acidas de sulfuro. | |
MX345893B (es) | Ensayo para clasificación de compuestos que disminuyen selectivamente el número de células madre de cáncer. | |
MX2020001171A (es) | Sistemas y metodos para realizar un ensayo de glicanos en tiempo real de una muestra. | |
MX2021003990A (es) | Metodos para detectar agonistas de ubiquitina ligasa. | |
MX2017005310A (es) | Metodos basados en proximidad para seleccion de parejas para ligadura. |